86 results
DEF 14A
CTCX
Carmell Corp - Ordinary Shares
14 Jun 24
Definitive proxy
8:24am
, including Purdue Pharma, where she was responsible for business development transactions for new therapeutic indications. Prior to Purdue, Ms. Gregory … was at Shire Pharmaceuticals and was responsible for business development transactions for the Neuroscience and Ophthalmology business units. Ms
424B3
CTCX
Carmell Corp - Ordinary Shares
5 Jun 24
Prospectus supplement
6:06am
stock covered by this prospectus as well as various related expenses. The Selling Stockholders are responsible for all selling commissions, transfer … . In addition, a responsible person will be required to report any serious adverse events that result from the use of a cosmetic product manufactured, packaged
8-K
EX-10.1
t9ocj 8vl32bj
4 Apr 24
Carmell Announces $3.0 Million Private Placement
5:28pm
8-K
EX-10.2
oapa 2mexjh78
4 Apr 24
Carmell Announces $3.0 Million Private Placement
5:28pm
8-K
EX-99.1
2jf2ix46rx7x8oxz8s4
16 Jan 24
Carmell Corp Announces Addition of Dr. Gregory A. Buford to Scientific Advisory Board
7:07pm
8-K
EX-10.1
6764j
5 Jan 24
Departure of Directors or Certain Officers
4:39pm
8-K/A
EX-99.2
2raiu5r3mrtdh34n20
25 Oct 23
Unaudited Condensed Financial Statements
4:02pm
8-K/A
EX-99.1
veiekvk7fsjxu2aha4ju
25 Oct 23
Unaudited Condensed Financial Statements
4:02pm